Get the Stockscreener App
16.91
0.06%
-0.01
After Hours:
16.96
0.05
+0.30%
Maplight Therapeutics Inc stock is traded at $16.91, with a volume of 248.20K.
It is down -0.06% in the last 24 hours and up +0.00% over the past month.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.
See More
Previous Close:
$16.92
Open:
$17
24h Volume:
248.20K
Relative Volume:
11.39
Market Cap:
$700.98M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$15.16
$17.56
1-Week Range:
$15.00
$18.84
52-Week Range:
$15.00
$18.84
Maplight Therapeutics Inc Stock (MPLT) Company Profile
Name
Maplight Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare MPLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MPLT
Maplight Therapeutics Inc
|
16.91 | 700.98M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Maplight Therapeutics Inc Stock (MPLT) Latest News
Long term debt to total assets ratio of MapLight Therapeutics, Inc. – BOATS:MPLT - TradingView
MapLight Therapeutics, Inc. Cash Flow – BOATS:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) options chain - Yahoo! Finance UK
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN
MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada
Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights
MapLight Therapeutics Closes Successful IPO and Private Placement - MSN
Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks
Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals
MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com
Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks
MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada
MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Total equity of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total liabilities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted earnings per share (diluted EPS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Revenue Breakdown – NASDAQ:MPLT - TradingView
Total liabilities & shareholders' equities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted net income available to common stockholders of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Net debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Inventory turnover of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating expenses (excl. COGS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Taxes of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Financial Statements – NASDAQ:MPLT - TradingView
Total revenue of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total operating expenses of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Gross profit of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Net income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Cost of goods sold of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Non-operating income (total) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Pretax income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
After tax other income/expense of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted shares outstanding of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Earnings and Revenue – NASDAQ:MPLT - TradingView
Dilution adjustment of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Price to cash flow ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
EBITDA margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Balance Sheet – NASDAQ:MPLT - TradingView
Non-controlling/minority interest of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Quick ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Muscarinic path still charting as Maplight IPO gets $258M - BioWorld MedTech
MapLight Therapeutics, Inc. Income Statement – NASDAQ:MPLT - TradingView
Net margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Statistics – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Maplight Therapeutics Inc Stock (MPLT) Financials Data
There is no financial data for Maplight Therapeutics Inc (MPLT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):